U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT07492355) titled 'TP-3654 Food Effect Study' on March 19.
Brief Summary: This clinical trial will determine the bioavailability and effect of food on TP-3654 in healthy adult participants.
Study Start Date: March 04, 2024
Study Type: INTERVENTIONAL
Condition:
Myelofibroses
Intervention:
DRUG: TP-3654
capsule, oral administered
Recruitment Status: COMPLETED
Sponsor: Sumitomo Pharma America, Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....